Pfizer reports Q2 earnings of 60 cents per share, beating 46 cents estimate Full-year revenue forecast raised to $59.5-$62.5 billion range Company targets $4 billion in cost savings by end of 2024 ...

Pfizer is positioning for a potential long-term rebound following a steep post-COVID revenue decline and a drop of over 50% ...

Pfizer (NYSE:PFE) shares rose more than 1% at the start of trading on Tuesday after the drugmaker hiked full-year guidance and reported better-than-expected Q2 earnings and revenue. The company’s ...

Pfizer shares tanked again last week after warning 2024 sales could be almost $5 billion (€4.54 billion) below market expectations. Shares have more than halved over the past year, falling to ...

Pfizer (PFE) will report second-quarter 2023 results on Aug 1, before market open. In the last reported quarter, the company beat earnings expectations by 23.0%. Pfizer’s revenues are expected ...

Pfizer (PFE) reports Q2 earnings on the morning of July 28. ... Jabil Stock Jumps on Strong Earnings, Outlook. Carnival Posts Better-Than-Expected Results on 'Incredibly Strong Demand' ...

Pfizer (PFE) delivered earnings and revenue surprises of 19.64% and 2.03%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Pfizer Inc. raised the lower end of its earnings forecast for the year and reiterated its sales expectations despite unfavorable currency trends. The drugmaker continues to project its new Covid ...

Analysts estimate adjusted EPS of $0.97 vs. $0.78 in Q2 FY 2020. Pfizer revenue is expected to grow at the fastest rate in at least 14 quarters, nearly doubling from Q2 FY 2020.